Airiver Nasal Drug Coated Balloon Catheter
Clinical- Indications
- Chronic rhinosinusitis, Nasal polyps
Company intelligence / Profile preview
Airiver Medical
Maryland, United Statesglobaldata.com ↗
- Ownership
- Private
- Development stage
- Clinical
01
Overview
Pioneering use of drug coated balloons delivering paclitaxel locally into airways/nasal passages. Early human studies ongoing targeting benign obstructions/chronic sinus disease aiming at first-line therapy status if successful.
- Therapeutic areas
- Pulmonology
- Modalities
- DeviceDrug-coated balloonPaclitaxel-coated device
- Industry
- Therapeutic Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Request access →03
Partnerships
Clinical Accelerator
Beyond the preview
Go deeper on Airiver Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Airiver Medical.